Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| anemia prostate cancer |
|
Orchiectomy | Prostate Cancer Information | UPMC Cancer Centers Since anemia is a common side effect of long-term androgen deprivation, The Prostate Cancer pages of this Web site are part of the Comprehensive Anemia Linked To Advanced Prostate Cancer Survival Worsening Anemia Signals Poorer Outcomes In Men Treated For Advanced Prostate Cancer (May 23, 2006) Prostate Cancer - Chemotherapy (Written Primarily For The Medical Since prostate and breast cancer are strikingly similar in so many ways, toxicity such as low white blood cell counts, anemia, and low platelet counts. Anemia during Prostate Cancer Chemotherapy prostate cancer chemotherapy may damage bone marrow and cause anemia. Anemia in Cancer Patients: Introduction and Overview Notable among these are solid tumor malignancies, such as breast and prostate cancer, that invade the marrow. Often overlooked as factors in inducing anemia Monitoring anemia provides clues to prostate cancer treatment response Researchers from the Oregon Health & Science University Cancer Institute and Southwest Oncology Group have identified a new method of determining how men MedlinePlus Medical Encyclopedia: Prostate cancer The appropriate treatment of prostate cancer is often controversial. Complete blood count (CBC) to monitor for signs and symptoms of anemia eMedicine - Prostate Cancer: Metastatic and Advanced Disease Manifestations of metastatic and advanced prostate cancer may include anemia, bone marrow suppression, weight loss, pathologic fractures, Prostate Cancer Research Institute - Anemia Associated with To describe the incidence, time to onset and extent of anemia occurring in patients with prostate cancer receiving combined hormone blockade (CHB) and the Prostate Cancer Research Institute - Research PCRI has been involved in major inroads in prostate cancer therapy, also muscle and bone loss, anemia, hot flashes, emotional lability with easy crying, Anemia in Men with Advanced Prostate Cancer: Incidence, Etiology Anemia associated with advanced prostate cancer is a common occurrence. This article reviews the incidence and examines the various causes of this condition |
| anemia prostate cancer |
|
gland picture prostate avodart prostate cancer by cancer caused prostate pten gleason score for prostate cancer |